Inhibitory and excitatory synaptic neuroadaptations in the diazepam tolerant brain.
Benzodiazepine
GABA(A) receptor
NMDA receptor
Proteomics
Sedation
Tolerance
Journal
Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
12
05
2023
revised:
20
07
2023
accepted:
31
07
2023
medline:
4
9
2023
pubmed:
4
8
2023
entrez:
3
8
2023
Statut:
ppublish
Résumé
Benzodiazepine (BZ) drugs treat seizures, anxiety, insomnia, and alcohol withdrawal by potentiating γ2 subunit containing GABA type A receptors (GABA
Identifiants
pubmed: 37536384
pii: S0969-9961(23)00263-2
doi: 10.1016/j.nbd.2023.106248
pmc: PMC10578451
mid: NIHMS1928221
pii:
doi:
Substances chimiques
Diazepam
Q3JTX2Q7TU
Receptors, GABA-A
0
Benzodiazepines
12794-10-4
gamma-Aminobutyric Acid
56-12-2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
106248Subventions
Organisme : NIA NIH HHS
ID : R01 AG065594
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH114908
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM133332
Pays : United States
Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors have no disclosures and declare no conflict of interest.
Références
Nat Rev Neurosci. 2013 Jun;14(6):383-400
pubmed: 23686171
Ann Clin Transl Neurol. 2020 Apr;7(4):527-542
pubmed: 32243088
Brain Res. 2005 Aug 9;1052(2):156-62
pubmed: 16009352
J Biol Chem. 1992 Jan 25;267(3):1426-9
pubmed: 1346133
Mol Pharmacol. 1996 Nov;50(5):1253-61
pubmed: 8913357
Pharmacol Biochem Behav. 1998 Apr;59(4):925-34
pubmed: 9586850
Am J Public Health. 2016 Apr;106(4):686-8
pubmed: 26890165
J Neurosci. 2013 Jan 16;33(3):1062-7
pubmed: 23325244
J Neurosci. 2010 Oct 20;30(42):13955-65
pubmed: 20962217
J Pharmacol Exp Ther. 1996 Apr;277(1):484-90
pubmed: 8613958
J Neurosci. 2007 Nov 7;27(45):12367-77
pubmed: 17989301
Behav Genet. 2000 Jul;30(4):285-93
pubmed: 11206083
Am J Psychiatry. 2007 Mar;164(3):519-23
pubmed: 17329479
Mol Pharmacol. 1994 Apr;45(4):618-25
pubmed: 8183240
Neuropharmacology. 2009 Jan;56(1):141-8
pubmed: 18760291
Nature. 2019 Jan;565(7740):454-459
pubmed: 30602790
Neuropsychopharmacology. 2009 Jan;34(2):290-8
pubmed: 18563060
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6889-93
pubmed: 8341715
Mol Cell Proteomics. 2012 Dec;11(12):1670-81
pubmed: 22942359
Pharmacol Biochem Behav. 1996 Apr;53(4):791-7
pubmed: 8801580
Clin Exp Pharmacol Physiol. 1986 Jan;13(1):1-8
pubmed: 3086004
Pain. 1995 Jun;61(3):365-374
pubmed: 7478679
Front Mol Neurosci. 2018 Dec 04;11:445
pubmed: 30564099
Clin Exp Pharmacol Physiol. 1986 Feb;13(2):153-8
pubmed: 3086005
Psychopharmacology (Berl). 1984;82(3):161-3
pubmed: 6425894
Nature. 1998 Apr 30;392(6679):926-30
pubmed: 9582073
J Physiol. 1995 Dec 1;489 ( Pt 2):529-43
pubmed: 8847645
Mol Pharmacol. 2003 Jan;63(1):53-64
pubmed: 12488536
J Biol Chem. 2011 Jul 15;286(28):25187-200
pubmed: 21606495
Alcohol. 1998 Jan;15(1):9-18
pubmed: 9426832
Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19902-7
pubmed: 17179037
Eur J Pharmacol. 2003 Mar 28;465(1-2):199-200
pubmed: 12650850
J Biol Chem. 2007 Nov 9;282(45):33052-63
pubmed: 17875639
Nat Commun. 2018 May 25;9(1):2069
pubmed: 29802289
Mol Brain. 2013 Feb 14;6:10
pubmed: 23410178
J Pharmacol Exp Ther. 2006 May;317(2):901-9
pubmed: 16505162
Brain Res Mol Brain Res. 1995 Sep;32(2):271-8
pubmed: 7500838
PLoS One. 2012;7(8):e43054
pubmed: 22912786
Curr Neuropharmacol. 2008 Mar;6(1):39-54
pubmed: 19305787
Physiol Rev. 2011 Jan;91(1):119-49
pubmed: 21248164
Pain. 2001 Dec;94(3):245-253
pubmed: 11731061
Mol Pharmacol. 1999 Jul;56(1):39-45
pubmed: 10385682
Mol Pharmacol. 1990 May;37(5):710-9
pubmed: 1692607
Brain Res. 1986 Aug 6;379(2):364-6
pubmed: 3017512
Trends Pharmacol Sci. 2018 Jul;39(7):659-671
pubmed: 29716746
Annu Rev Biochem. 2011;80:247-71
pubmed: 21548785
Neurosci Lett. 2006 Sep 1;404(3):266-9
pubmed: 16824682
Proc Natl Acad Sci U S A. 2014 May 13;111(19):7132-7
pubmed: 24778259
Pharmacol Biochem Behav. 1994 Apr;47(4):823-6
pubmed: 8029250
J Biol Chem. 2010 Dec 31;285(53):41795-805
pubmed: 20940303
Life Sci. 1994;54(20):PL339-50
pubmed: 7514710
Nat Neurosci. 2000 Jun;3(6):587-92
pubmed: 10816315
J Physiol. 2007 Nov 15;585(Pt 1):29-46
pubmed: 17855751
Trends Neurosci. 2004 Sep;27(9):569-75
pubmed: 15331240
Br J Pharmacol. 1995 Nov;116(5):2375-84
pubmed: 8581272
J Neurosci. 2012 Apr 25;32(17):5707-15
pubmed: 22539833
Commun Biol. 2019 May 1;2:153
pubmed: 31069263
J Neurophysiol. 2012 Apr;107(8):2232-43
pubmed: 22236713
Nat Methods. 2019 Jun;16(6):509-518
pubmed: 31133760
Nature. 1999 Oct 21;401(6755):796-800
pubmed: 10548105
Front Cell Neurosci. 2019 Apr 26;13:163
pubmed: 31080408
Nature. 2022 Apr;604(7904):190-194
pubmed: 35355020
J Biol Chem. 2009 Jun 19;284(25):17253-17265
pubmed: 19380581
J Neurosci. 2004 Jul 28;24(30):6785-90
pubmed: 15282283
Front Mol Neurosci. 2022 Oct 03;15:1017404
pubmed: 36263376
Pain. 2000 Apr;85(3):395-404
pubmed: 10781912
Cereb Cortex. 2006 Apr;16(4):541-52
pubmed: 16033926
J Proteome Res. 2019 Oct 4;18(10):3800-3806
pubmed: 31475827
Annu Rev Physiol. 1995;57:417-45
pubmed: 7778873
Curr Pharm Des. 2002;8(1):5-21
pubmed: 11812247
Nat Neurosci. 2005 Jun;8(6):797-804
pubmed: 15895085
Adv Pharmacol Sci. 2012;2012:416864
pubmed: 22536226
Nat Commun. 2018 Dec 3;9(1):5128
pubmed: 30510204
Pharmacol Rev. 2021 Oct;73(4):298-487
pubmed: 34753794
J Neurochem. 2002 Jul;82(1):110-7
pubmed: 12091471
Pharmacol Rev. 2008 Sep;60(3):243-60
pubmed: 18790874
J Pain Symptom Manage. 2000 Jan;19(1 Suppl):S7-11
pubmed: 10687332